This article reviews the glucagon-like peptide 1 (GLP-1) agonistbased therapies as a new class of antidiabetic and their potential effects beyond glucose control that may ultimately impact cardiovascular disease
Confirm whether the medication is compounded or FDA-approved
The elastic fibers that allow skin to snap back become damaged over time, and rapid weight loss doesnt give these fibers adequate time to adjust
Among their many functions, hormones regulate metabolism, appetite, and fat distribution in the body
Safety and Efficacy of Once-Weekly Dulaglutide Versus Sitagliptin After 2 Years in Metformin-Treated Patients With Type 2 Diabetes (AWARD-5): A Randomized, Phase III Study
This observation led to a study where GLP-1 was given to obese patients with T2DM and showed improved glycemic control with no side effects, establishing a proof-of-concept for GLP-1 agonists, which over time led to their use in the treatment of T2DM patients [21]
%20(1).png)